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Abstract
The mitochondrial cAMP-dependent protein kinase (PKA) is activatable in a cAMP-independent
fashion. The regulatory (R) subunits of the PKA holoenzyme (R2C2), but not the catalytic (C)
subunits, suffer proteolysis upon exposure of bovine heart mitochondria to digitonin, Ca2+, and a
myriad of electron transport inhibitors. Selective loss of both the RI- and RII-type subunits was
demonstrated via western blot analysis and activation of the C subunit was revealed by
phosphorylation of a validated PKA peptide substrate. Selective proteolysis transpires in a calpain-
dependent fashion as demonstrated by exposure of the R and C subunits of PKA to calpain and by
attenuation of R and C subunit proteolysis in the presence of calpain inhibitor I. By contrast,
exposure of mitochondria to cAMP fails to promote R subunit degradation, although it does result
in enhanced C subunit catalytic activity. Treatment of mitochondria with electron transport chain
inhibitors rotenone, antimycin A, sodium azide, and oligomycin, as well as an uncoupler of
oxidative phosphorylation, also elicits enhanced C subunit activity. These results are consistent
with the notion that signals, originating from cAMP-independent sources, elicit enhanced
mitochondrial PKA activity.
Members of the protein kinase family have been implicated in a myriad of processes, from
ATP generation to unrestrained growth and division.(1) Although the cAMP-dependent
protein kinase (PKA) is commonly held as the prototypical protein kinase, its mechanism of
activation is atypical relative to nearly all other protein kinase family members. PKA is
inactive in its holoenzyme form, a tetrameric species consisting of two regulatory (R) and
two catalytic (C) subunits. Upon binding of cAMP to the R subunits, the C subunits are
released, and are thus free to catalyze the phosphorylation of an array of proteins.(2, 3)
However, it is now recognized that PKA can be activated in a cAMP-independent fashion as
well. For example, the C subunit can exist in an inactive state via association with IκB in an
NF-κB-IκB-(C subunit) complex. Stimulation of cells with lipopolysaccharide, endotheln-1,
or angiotensin II induces IκB degradation, resulting in the ensuing C subunit-catalyzed
phosphorylation of NF-κB p65.(4, 5) In addition, it has been recently reported that thrombin
and collagen trigger the dissociation of the C subunit from IκB via a PI3K-dependent
pathway.(6) A somewhat analogous proteasome-mediated R-subunit degradation/C-subunit
activation mechanism has been reported as well.(7) However, in this case, ubiquitination of
the R subunit is cAMP-dependent.(8) The active C subunit generated via this process has
been linked to the regulation of hippocampal synaptic plasticity. Proteolysis has not only
been shown to promote PKA activity, but recently C subunit degradation has been observed
in a pathological state as well. Specifically, overactive calpain has been identified in
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diseased neurons from Alzheimer’s patients, where it induces the proteolysis of both the R
and C subunits of PKA.(9) Shaltiel and his collaborators demonstrated, in a series of papers,
that the C subunit is inactivated by Zn2+-metalloprotease-mediated proteolysis.(10, 11)
There have been several reports describing the concerted action of PKA and calpain,
including the regulation of platelet procoagulant activity(12), D1 receptor-mediated
phosphorylation of tau(13), and the PKA-catalyzed phosphorylation of the calpain inhibitor
calpastatin(14, 15), to name but a few. Calpains are a class of ubiquitously expressed Ca2+-
activated cysteine proteases. Recent studies have shown that calpain-1 (µ-calpain), calpain-2
(m-calpain), and calpain-10 are present in the mitochondria (16–18), an organelle with
significant PKA activity(19–22). Both calpain-1, which requires micromolar levels of Ca2+,
and calpain-2, which requires millimolar levels of Ca2+, are located in the mitochondrial
intermembrane space, while calpain-10 is embedded within the matrix. PKA, like the
calpains, is interspersed throughout the major mitochondrial compartments.(22) Finally, the
calpains(23, 24) and PKA(25) are known play key roles in mediating (and blocking)
apoptosis.
We have examined the relationship between mitochondrial calpain and PKA activity, and
have discovered that calpain activates the R2C2 holoenzyme in a cAMP-independent
fashion. A variety of agents, including inhibitors of the electron transport chain, activate
calpain in a Ca2+-dependent manner, which in turn, catalyzes the proteolysis of the R
subunit, thereby releasing the C subunit in its active form.
MATERIALS AND METHODS
Reagents and antibodies
PKA R and C subunits (from bovine heart), PKA holoenzyme, Leu-Arg-Arg-Ala-Ser-Leu-
Gly (kemptide), rotenone, sodium azide, antimycin A, oligomycin, carbonyl cyanide 3-
chlorophenylhydrazone (CCCP), calpain inhibitor I N-acetyl-Leu-Leu-Nle-CHO (ALLN),
antibodies against calpain-1, calpain-2, and calpain-10 were purchased from Sigma.
Calpain-1 was purchased from Calbiochem, and phospholipase A2 was purchased from
Worthington Biochemical. Bovine heart mitochondria and MitoProfile® Membrane
Integrity Western blot antibody cocktail were purchased from Mitosciences. The antibodies
against the PKA C subunit, RI subunit, RII subunit, calnexin, glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), and cytochrome c were purchased from BD Biosciences while
the goat anti-mouse HRP-conjugated secondary antibody was purchased from Santa Cruz
Biotechnology. Protein quantification was accomplished using the BCA protein assay
(Pierce). Immunoblots were performed using Snap i.d. (Millipore), and detection was
accomplished using SuperSignal West Pico chemiluminescent substrate (Pierce). The
resulting images were visualized and quantified using an AlphaInnotech FluorChem FC 2
imager. The intactness of the isolated mitochondria was assessed via a previously described
protocol.(26)
Western blot analyses
25 µg of total protein was loaded onto 4 - 12% bis-Tris polyacrylamide gels, separated by
electrophoresis, and electroblotted onto PVDF membranes. The membranes were then
blocked in 0.5% nonfat dry milk followed by incubation with the appropriate primary
antibody (C subunit 1:1000, RI: 1:1000, RII: 1:1000, calnexin 1:4000, GAPDH 1:5000,
cytochrome c 1:1000, Na+/K+ ATPase 1:2000, calpain-1 1:1000, calpain-2 1:1000,
calpain-10 1:1000) for 10 min (C subunit, calnexin, GAPDH, cytochrome c, Na+/K+
ATPase) or 2 × 20 min (RI and RII). The membranes were then washed 3 times with 0.1%
Tween-20 in PBS followed by incubation with a goat anti-mouse secondary antibody
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(1:2000) for 10 min. Subsequent washes with 0.1% Tween-20 in PBS (3x), PBS (3x), and
0.5 % NaCl (3x) were performed prior to detection.
Assessment of Mitochondrial Purity and Integrity
The purity of bovine heart mitochondria isolated was assessed via western blot analysis
using antibodies against proteins localized to mitochondrial (cytochrome c) and non-
mitochondrial sites, including the endoplasmic reticulum (calnexin), the plasma membrane
(Na+/K+ ATPase), and the cytosol (GAPDH) (data not shown). The mitochondrial
preparation is not contaminated with proteins from other membranes or the ER, and displays
only minimal contamination from the cytoplasm. Mitochondrial structural integrity (>90%)
was assessed via measurement of cytochrome c oxidase activity.(26)The mitochondria were
also probed via western blot for the presence of calpain and were found to contain calpain-1
and calpain-10, but not calpain-2 (data not shown).
Calpain Digestion of Isolated R and C Subunits of PKA and the PKA Holoenzyme
0.4 µg of calpain 1 was added to 0.9 µg of C or R subunit in the presence or absence of
calpain inhibitor I (200 µM). The reaction was initiated by the addition of 1 mM, 100 µM,
10 µM, 7 µM, 5 µM, or 2 µM CaCl2, and incubated at 37 °C for 20 min. For digestion of the
holoenzyme, 0.8 µg calpain 1 was added to 5 µg of holoenzyme, and the reaction was
initiated by the addition of 100 µM CaCl2. The reaction was allowed to incubate at 37 °C for
30 min, 1 h, or 2 h. Reactions were stopped by the addition of loading buffer (106 mM Tris
HCl, 141 mM Tris base, 2% LDS, 10% glycerol, 0.51 mM EDTA, 0.22 mM SERVA® Blue
G250, 0.175 mM phenol red, pH 8.5), and the samples were run on a 4–12% bis-tris
polyacrylamide gel, and the resulting gel was stained with Coomassie blue.
Digitonin/Ca2+ Treatment of Bovine Heart Mitochondria
Mitochondria were suspended in a hypotonic buffer (0.08 M sucrose, 0.1 mM EDTA, 10
mM Tris-HCl, pH 7.4) and allowed to incubate for 30 min on ice in the presence or absence
of 200 µM calpain inhibitor I. The samples were then treated in the presence or absence of
digitonin (0.5 mg/mg mitochondrial protein), phospholipase A (4.4 U/mg protein), in the
presence or absence of CaCl2 (100 µM), and allowed to incubate at 37 °C for 2 h (in the
presence of digitonin) or 5 min – 2 h (in the absence of digitonin). For mitoplast preparation,
digitonin-treated samples were pelleted at 11 000 × g for 15 min.
Calpain Digestion of Bovine Heart Mitochondria
All samples containing calpain inhibitor I were incubated for 30 min prior to calpain
treatment. 0.4 µg of calpain 1 was added to the mitochondria in the presence and absence of
calpain inhibitor I (200 µM) followed by the addition of CaCl2 (10 µM). The samples were
allowed to incubate at 37 °C for 20 min. The reaction was stopped by the addition of loading
buffer (106 mM Tris HCl, 141 mM Tris base, 2% LDS, 10% glycerol, 0.51 mM EDTA, 0.22
mM SERVA® Blue G250, 0.175 mM phenol red, pH 8.5).
Calpain Activity Assay
Calpain activity was assessed spectrophotometrically using the calpain substrate N-succinyl-
Leu-Tyr-7-amido-4-methylcoumarin as previously described.(27) Mitochondria (275 µg
whole mitochondria) were pelleted at 9,500 × g for 10 min at 4 °C, resuspended in a
hypotonic buffer (0.08 M sucrose, 0.1 mM EDTA, 10 mM Tris-HCl, pH 7.4) for digitonin
treatment, or in an isotonic buffer (0.25 M sucrose, 0.1 mM EDTA, 10 mM Tris HCl, pH
7.4) for CaCl2 treatment, and incubated for 30 min on ice. The samples were then treated
with digitonin (0.5 mg/mg mitochondrial protein) and phospholipase A (4.4 U/mg protein)
or CaCl2 (100 µM) in the presence of 100 µM N-succinyl-Leu-Tyr-7-amido-4-
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methylcoumarin. Activity was measured using excitation and emission wavelengths of 355
and 444 nm, respectively.
Mitochondria Release Assays
All mitochondrial samples were centrifuged at 9,500 × g for 10 min at 4 °C, rinsed 3 times,
and resuspended in isotonic buffer (0.25 M sucrose, 0.1 mM EDTA, 10 mM Tris HCl, pH
7.4) containing 25 µM KH7 prior to use. Mitochondria were treated with CaCl2 (10 µM, 100
µM), rotenone (10 µM), sodium azide (2 mM), antimycin A (5 µM), oligomycin (5 µM), or
CCCP (5 µM) in the presence and absence of ALLN (500 µM) and incubated at 37 °C for
30 min. The samples were then centrifuged at 9,500 × g for 10 min at 4 °C, and the
supernatant was either analyzed by western blot or used in an enzyme-coupled assay in the
presence or absence of PKI (100 µM) via a previously described protocol(28) to detect PKA
activity.
RESULTS AND DISCUSSION
Our initial experiments focused on purified bovine heart C and R subunits. Both were
subjected to proteolysis by calpain I (Figure 1). Although both are prone to calpain-mediated
digestion, the amount of Ca2+ profoundly dictates proteolytic selectivity. The C subunit
remains intact after treatment with calpain in the presence of 10 µM CaCl2, whereas the R
subunit is ~70% digested. However, if higher concentrations of Ca2+ (≥100 µM) are used,
some C subunit digestion occurs as well. The calpain inhibitor ALLN blocks the proteolysis
of the R subunit at all Ca2+ concentrations and of the C subunit at high Ca2+ levels. We
subsequently evaluated the calpain-mediated digestion of the R2C2 holoenzyme (Figure 2).
Curiously, only the R subunit of the holoenzyme suffers proteolysis. The C subunit remains
completely intact, even though the conditions employed (100 µM Ca2+) result in the partial
digestion of isolated C subunit (i.e. in the absence of R subunit). One possible explanation is
that calpain-catalyzed proteolysis in an in vitro setting generates R subunit fragments that
retain the ability to bind to and protect the C subunit from calpain. These results merit
further analysis. Most importantly, however, the selective sensitivity of the R subunit to
proteolysis suggests that an analogous phenomenon, in a physiological setting, could result
in the calpain-dependent activation of PKA. We explored the latter possibility using isolated
mitochondria from bovine heart.
Digitonin is known to trigger the release of Ca2+ from Ca2+ stores.(29) Given the fact that
calpains are Ca2+-dependent, we decided to explore whether digitonin and/or Ca2+ influence
mitochondrial PKA activity. Both RI and RII isoforms of PKA, but not the C subunit, are
partially digested upon exposure of mitochondria to digitonin (Figure 3A). Degradation is
prevented by the addition of the calpain inhibitor ALLN, implying a calpain-dependent
process. Furthermore, R subunit proteolysis is enhanced by the addition of Ca2+, likewise
consistent with the involvement of calpain, a Ca2+-dependent protease (Figure 3B). We also
employed the fluorescent calpain substrate, N-succinyl-Leu-Tyr-7-amido-4-methylcoumarin,
to examine mitochondrial calpain activity. Untreated mitochondria do not display calpain
activity (Figure 3C inset), whereas mitochondria exposed to either digitonin or Ca2+ exhibit
a time-dependent hydrolysis of the methylcoumarin-based fluorescent calpain substrate
(Figure 3C). These experimental results are all consistent with the notion that digitonin-
induced R subunit loss is mediated by calpain. A time course study of Ca2+-induced
digestion revealed that the maximum extent of R subunit proteolysis is approximately 25 –
35% (Figure 3D), indicating that some, but not all mitochondrial R subunit, is subject to
calpain-mediated digestion.
In contrast to Ca2+ and digitonin-exposure, R subunit digestion is not observed in
mitochondria treated with cAMP (Figure 4A). As a control, calpain I was added to
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mitochondria, and the relative amounts of RI, RII, and C subunits assessed by western blot
analysis. Once again, degradation of both RI and RII, but not C subunit, was observed
(Figure 4B). Approximately 30% of R subunit content is lost upon treatment with calpain
(Figure 4C). We’ve previously shown that the majority of PKA in bovine heart
mitochondria is contained within the matrix(22) and one might predict that the R subunits in
this compartment would be impervious to externally added calpain. The fact that the amount
of R subunit loss is similar, whether induced by added calpain or by digitonin, suggests that
only a fraction of the total mitochondrial PKA content is sensitive to calpain and that it is
likely this fraction is present outside of the matrix. However, given the structural nature of
mitochondria, it is challenging to assess the proteolytic sensitivity of R in the various
mitochondrial compartments. For example, we prepared mitoplasts in the conventional
digitonin-mediated fashion, but in the absence and presence of calpain inhibitor ALLN (Fig.
5). Mitoplasts prepared in the presence of ALLN display a 15% greater amount of intact R
than those prepared in the absence of inhibitor. It is tempting to speculate that R subunit
associated with the outer leaflet, as opposed to matrix R, is susceptible to digitonin-induced
calpaincatalyzed proteolysis. Of additional note is the formation of an R subunit fragment of
~36 kDa, which is not observed when isolated R subunit is treated with calpain.
We subsequently examined whether digestion of the R subunit leads to the release of active
C subunit. Mitochondria were exposed to either cAMP or CaCl2, centrifuged, and the
supernatant analyzed for active released C subunit. The experiments were performed in the
presence of KH7, a soluble adenylyl cyclase inhibitor, which was used to block the possible
generation of mitochondrial cAMP. As expected, mitochondrial exposure to cAMP
promotes the release of C subunit into the supernatant as evidenced by western blot analysis
(Figure 6A). We note that there is also C subunit associated with the pellet, an observation
consistent with our recent demonstration of PKA activity in the matrix.(22) As a control, we
found very little C subunit present in the supernatant when untreated mitochondria are
centrifuged (Figure 6A). In addition, Ca2+ promotes mitochondrial release of C subunit into
the supernatant (Figure 6A), and the latter is ameliorated by addition of the calpain inhibitor
ALLN (Figure 6B), consistent with the notion that this phenomenon is calpain-dependent.
The supernatant in these experiments was also examined for PKA activity, using a
previously described enzyme-coupled assay(28): (i) PKA: LRRASLG + ATP →
LRRApSLG + ADP (ii) pyruvate kinase: ADP + phosphoenol pyruvate → ATP + pyruvate
(iii) lactate dehydrogenase: pyruvate + NADH → lactate + NAD+. The supernatant from
untreated mitochondria displays a small amount of background kinase activity in the
enzyme-coupled assay. This may be due to the presence of mitochondrial ADP or pyruvate,
which would generate a response in the enzyme-coupled assay. Nonetheless, PKA activity
from the supernatant of Ca2+-treated mitochondria is 2.7 times greater than that of the
untreated control. Furthermore, in the presence of PKI, a selective PKA inhibitor, or in the
presence of ALLN (Figure 6D), no increase in supernatant PKA activity is observed. In
short, a calpain-mediated process liberates C subunit from the mitochondrial milieu as an
active enzyme.
Given that Ca2+ is an inducer of mitochondrial membrane permeability transition (MPT)(30,
31), we decided to investigate whether other agents known to cause MPT also activate PKA
in a calpain-dependent fashion. Electron transport chain inhibitors are widely linked to
induction of MPT due to depolarization of the mitochondrial membrane, loss of membrane
potential, and mitochondrial swelling.(32–35) In addition, uncouplers of oxidative
phosphorylation produce similar effects.(32–35) Therefore, we explored whether exposure
of mitochondria to electron transport chain inhibitors rotenone (complex I), antimycin A
(complex III), sodium azide (complex IV), and oligomycin (F1F0 ATPase), as well as the
uncoupler CCCP, elicits enhanced PKA activity. Mitochondria were treated with each of
these reagents in the presence and absence of calpain inhibitor ALLN, pelleted, and the
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supernatants analyzed for C subunit. Exposure of mitochondria to rotenone, azide, and
CCCP induced release of the C subunit into the supernatant, whereas the presence of ALLN
blocks release (Figure 7). The amount of C subunit released upon exposure to rotenone,
azide, and CCCP is 6.2, 4.3, and 3.2 times greater, respectively, than that of the untreated
control.
Antimycin A and oligomycin also stimulate C subunit release from the mitochondria, but to
a lesser extent (1.9 and 1.6 times greater, respectively, than that of an untreated control).
Release of C subunit in the antimycin A-treated sample is attenuated by ALLN, while
release is not affected by ALLN in the oligomycin-treated sample (Figure 7). A recent study
has shown that antimycin A induces calpain activation.(48) However, to the best of our
knowledge, oligomycin has not been demonstrated to activate calpain. Finally, the
supernatants in all of the mitochondria exposed to electron transport inhibitors were assayed
for PKA activity and, as expected, increased C subunit release (as revealed by western blot
analysis) parallels enhanced kinase activity (data not shown).
What are the possible consequences of stress-induced calpain-mediated PKA activation?
The activation of PKA by reagents that inflict mitochondrial stress may represent a
protective mechanism. Indeed, PKA activation is known to be cytoprotective. PKA activity
is associated with increased cell survival via phosphorylation of proapoptotic BAD protein.
(39–42) In addition, PKA phosphorylates apoptotic protease-activating factor 1 (Apaf-1),
preventing formation of the apoptosome and activation of caspase-9.(43) Furthermore, PKA
phosphorylates VDAC in vitro (44), which may prevent the leakage of cytochrome c and
thus inhibit apoptosis. The PKA-catalyzed phoshorylation of complex I increases
mitochondrial respiration.(36, 37) One possible explanation for rotenone’s induction of PKA
activity is that inhibition of complex I may trigger a feedback response (PKA-catalyzed
phosphorylation of complex I) to restore respiration. Indeed, this may be the case for azide-
induced (complex IV inhibition) activation of PKA as well since PKA phosphorylates
subunits of cytochrome c oxidase, which likewise promotes enhanced respiration rates.(38)
Consistent with our observation of the azide-triggered calpain-dependent activation of PKA
is a previous report that azide treatment of neonatal cardiomyocytes initiates calpain
activation.(45) Indeed, the more pronounced induction of the C subunit by rotenone
(complex I) and azide (complex IV) than either antimycin A (complex III) or oligomycin
(F1F0 ATPase) may be a consequence of the demonstrated PKA-catalyzed phosphorylation
of complexes I (36, 37) and IV (38). The latter may be consistent with a tight regulatory
feedback loop (vide infra) between PKA and complexes I and IV.
Finally, as noted above, mitochondria treated with CCCP also display enhanced C-subunit
activity. This is consistent with the fact that uncouplers of oxidative phosphorylation induce
Ca2+ release(46), a prerequisite for calpain activation. These results suggest the following
sequence of events in response to mitochondrial stress: MPT induction(32), release of matrix
Ca2+(47), activation of mitochondrial calpain, subsequent proteolyisis of the R subunits, and
release of active C subunits.
Given the observation that high Ca2+ concentrations can lead to calpain-induced C subunit
digestion (Figure 1), it is possible that a delicate balance exists between PKA activation and
inactivation. In particular, dysregulation of intracellular Ca2+ homeostasis is implicated in
many disease models. Mitochondria buffer cytosolic Ca2+ to a certain extent, but
mitochondrial Ca2+ overload leads to apoptotic and necrotic cell death.(31, 49) Calpains are
activated in Ca2+-induced apoptotic cell death and have been demonstrated to be involved in
the induction of MPT.(17) Indeed, PKA activity is downregulated in diseased neurons in the
presence of 2.5 mM Ca2+. A decrease in PKA activity is attributed to calpain digestion of
both R and C subunits.(9)
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Proteolytic regulation of PKA activity appears to be both an alternative to and synergistic
with cAMP activation. Examples of cAMP-independent regulation of PKA activity have
been reported involving activation of the C subunit via degradation of IκB.(4–6) In some
instances, such as with proteosomal regulation of the PKA holoenzyme and with calpain
regulation of PKA activity in Drosophila, elevation of cAMP levels is required prior to
proteolysis of R subunit.(8, 50) The calpain-dependent activation of mitochondrial C subunit
originates from non-cAMP-dependent sources, since activation occurs in the presence of
KH7 (see Figure 6), a soluble adenylate cyclase inhibitor.
In summary, we have demonstrated the digestion of the R subunits, but not the C subunits,
of PKA in bovine heart mitochondria in the presence of digitonin and/or Ca2+. Furthermore,
R subunit proteolysis is attenuated by the addition of calpain inhibitor ALLN. Exposure the
mitochondria to Ca2+ induces cAMP independent PKA activity, which is blocked by calpain
inhibitor I or by the PKA-specific inhibitor PKI. Metabolic inhibitors rotenone, sodium
azide, antimycin A, and CCCP also elicit enhanced C subunit activity in a calpain-dependent
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Abbreviations
ALLN calpain inhibitor I N-acetyl-Leu-Leu-Nle-CHO
C subunit catalytic subunit
CCCP chlorophenylhydrazone
GAPDH glyceraldehyde 3-phosphate dehydrogenase
kemptide Gly-Arg-Arg-Ala-Ser-Leu-Gly
PKA cAMP-dependent protein kinase
PKI protein kinase inhibitor
R subunit regulatory subunit
R2C2 PKA holoenzyme
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Figure 1. Calpain Digestion of Bovine PKA R and C Subunits
Calpain 1 was added to C or R (I and II) subunit in the presence or absence of ALLN. The
reaction was initiated by the addition of variable concentrations of CaCl2, and incubated at
37 °C for 20 min: R subunit (♦), C subunit (▲), R subunit and ALLN (●), and C subunit and
ALLN (X).
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Figure 2. Calpain Digestion of Intact Bovine R2C2 Holoenzyme
Calpain 1 was added to the R2C2 holoenzyme in the presence of 100 µM CaCl2 for 0.5, 1.5,
and 2.0 h and the C (○) and R (●) subunits subsequently quantified via western blot analysis
(inset).
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Figure 3. Digitonin and Ca2+-induced digestion of mitochondrial PKA
A. Bovine heart mitochondria incubated with digitonin in the presence or absence of ALLN
where black bar = untreated mitochondria, dark gray bar = digitonin-exposed mitochondria,
and the light gray bar = digitonin and ALLN (calpain inhibitor I)-exposed mitochondria. B.
Bovine heart mitochondria incubated with digitonin and CaCl2 in the presence or absence of
ALLN where black bar = untreated mitochondria, dark gray bar = digitonin/CaCl2-exposed
mitochondria, and the light gray bar = digitonin/CaCl2 and ALLN (calpain inhibitor I)-
exposed mitochondria. C. Calpain activity (assessed utilizing the fluorescent substrate N-
succinyl-Leu-Tyr-7-amido-4-methylcoumarin) from bovine heart mitochondria incubated
with digitonin (black trace), digitonin and CaCl2 (gray trace), or buffer alone (inset). D.
Bovine heart mitochondria incubated with CaCl2 in the presence or absence of ALLN as a
function of time where the black trace is the rate of proteolysis of RI and the gray trace the
rate of proteolysis of RII. Immunoblots were imaged using an AlphaInnotech FC2, and
quantified using Fluorchem FC2 software. The data represents the mean of 3 experiments ±
SEM.
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Figure 4. Mitochondrial R and C subunit integrity in response to cAMP and calpain
Mitochondria were treated with (A) cAMP or (B) calpain I and CaCl2. Calpain-exposed
mitochondria were examined in the presence or absence of ALLN. Immunoblots were
imaged using an AlphaInnotech FC2, and quantified using Fluorchem FC2 software.
Quantification of untreated (black bar), calpain I-exposed (dark gray bar), and calpain I/
ALLN-exposed (light gray bar) mitochondria are shown in C. The data represents the mean
of three experiments ± SEM.
Shell and Lawrence Page 14













Figure 5. Mitoplast-associated R subunit content from mitochondria treated with digitonin in the
absence and presence of ALLN
Mitochondria were treated with digitonin (0.5 mg/mg protein) and phospholipase A in the
presence or absence of ALLN (200 µM) and incubated at 37°C for 2 h. The resultant
mitoplasts were then pelleted at 11,000 × g for 15 min at 4 °C.
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Figure 6. Ca2+-induced PKA activation: release of active C subunit
A. Mitochondria were treated with cAMP or CaCl2, centrifuged, and the pellet and
supernatant processed for western blot analysis. B. Mitochondria were incubated with the
soluble adenylate cyclase inhibitor KH7 for 30 min, then treated with CaCl2 in the presence
or absence of ALLN, centrifuged, and the supernatant analyzed for C subunit by western
blot: untreated (black bar), Ca2+-exposed (dark gray bar), and Ca2+/ALLN-exposed (light
gray bar) mitochondria. C. PKA activity, using a previously described enzyme-coupled
assay(21), in untreated (light gray trace) and cAMP-exposed (black trace) mitochondria. D.
PKA activity in Ca2+-exposed (black trace), Ca2+/ALLN-exposed (light gray trace), and
Ca2+/PKI-exposed mitochondria (dark gray trace).
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Figure 7. Metabolic inhibitors induce activation of PKA in a calpain-dependent fashion
Mitochondria were exposed to oligomycin, antimycin A, rotenone, CCCP, or sodium azide
in the presence or absence of ALLN for 30 min at 37 °C and subsequently centrifuged. The
supernatants were analyzed by western blot for the presence of the C subunit. The relative
amount of C subunit released from untreated (black bar), metabolic inhibitor-exposed (gray
bar), and metabolic inhibitor/ALLN-exposed mitochondria. The data represents the mean of
three experiments ± SEM.
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